ULTRIBON Trademark

Trademark Overview


On Thursday, December 19, 2013, a trademark application was filed for ULTRIBON with the United States Patent and Trademark Office. The USPTO has given the ULTRIBON trademark a serial number of 86147999. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 7, 2017. This trademark is owned by Novartis AG. The ULTRIBON trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations ...
ultribon

General Information


Serial Number86147999
Word MarkULTRIBON
Filing DateThursday, December 19, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 7, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 6, 2014

Trademark Statements


Goods and ServicesAnti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 6, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, August 7, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 7, 2017ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 10, 2017EXTENSION 5 GRANTED
Friday, December 30, 2016EXTENSION 5 FILED
Friday, December 30, 2016TEAS EXTENSION RECEIVED
Wednesday, July 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 12, 2016EXTENSION 4 GRANTED
Thursday, June 30, 2016EXTENSION 4 FILED
Thursday, June 30, 2016TEAS EXTENSION RECEIVED
Saturday, January 9, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 8, 2016EXTENSION 3 GRANTED
Wednesday, December 30, 2015EXTENSION 3 FILED
Wednesday, December 30, 2015TEAS EXTENSION RECEIVED
Thursday, July 23, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 22, 2015EXTENSION 2 GRANTED
Friday, June 26, 2015EXTENSION 2 FILED
Wednesday, July 22, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 26, 2015TEAS EXTENSION RECEIVED
Friday, January 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 31, 2014EXTENSION 1 GRANTED
Wednesday, December 31, 2014EXTENSION 1 FILED
Wednesday, December 31, 2014TEAS EXTENSION RECEIVED
Tuesday, July 1, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 6, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 6, 2014PUBLISHED FOR OPPOSITION
Wednesday, April 16, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 27, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 26, 2014ASSIGNED TO EXAMINER
Monday, January 6, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 23, 2013NEW APPLICATION ENTERED IN TRAM